About Us
Investor Relations
Corporate Profile
Calendar
Presentations
Press Releases
Corporate Governance
Management
Board of Directors
Committee Composition
Contact the Board
Insider Transactions
Financial Information
SEC Filings
Financial Reports
Quarterly Results
Key Ratios
Stock Information
Historic Stock Lookup
Investment Calculator
Dividend History
Analyst Coverage
Ownership Profile
Investor FAQs
Contact Us
Email Alerts
Newsroom
Marketed Products
ARCALYST
®
(rilonacept)
Clinical Pipeline
Aflibercept (VEGF Trap)
VEGF Trap - Eye
Rilonacept (IL-1 Trap)
Research Focus Areas
Angiogenesis
Oncology
Ophthalmology
Cardiovascular Diseases
Immunity and Inflammation
Infectious Diseases
Metabolic Diseases and Obesity
Muscle Disorders
Pain
Bone Disease
Research Publications
Technology Platforms
VelociGene
®
VelociMouse
®
VelocImmune
®
Antibodies
Traps
Protein Production
VelociMab™
Industrial Capabilities
Careers
Contact Us
Site Map
SEARCH
Calendar
Upcoming Events
Details on upcoming events are not yet available. Please
click here
to be notified of all upcoming events.
Archived Events
Aug 13, 2010
11:20 AM ET
Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference
Listen to webcast.
View Presentation
1.7 MB
Jul 15, 2010
9:00 AM ET
Regeneron 2010 Investor Day
Listen to webcast.
Note:
These videos were shown at the meeting but not webcast.
You may view them here at any time.
VelociGene® and VelocImmune® Technologies: A Brief History
Process Development and Manufacturing
Introduction: Leonard Schleifer, M.D., Ph.D., Chief Executive Officer
3.3 MB
R&D Overview: George Yancopoulos, M.D., Ph.D., Chief Scientific Officer
8.8 MB
Early Clinical Development: Neil Stahl, Ph.D., Senior Vice President, Research and Development Sciences
1.8 MB
Early Stage Development: Peter Powchik, M.D., Senior Vice President, Clinical Development
1.7 MB
Oncology: Alain Thibault, M.D., Vice President, Clinical Sciences, Oncology
1.1 MB
VEGF TrapEye: Robert Vitti, M.D., Executive Director, Clinical Sciences, Ophthalmology
8.7 MB
ARCALYST® (rilonacept): Bob Terifay, Senior Vice President, Commercial
2.3 MB
Financial Overview: Murray Goldberg, Chief Financial Officer
929.3 KB
Industrial Operations and Product Supply: Dan Van Plew, Senior Vice President, Industrial Operations and Product Supply
5.5 MB
Conclusion: Leonard Schleifer, M.D., Ph.D., Chief Executive Officer
2.1 MB
Jun 16, 2010
5:40 PM ET
Goldman Sachs 31st Annual Global Healthcare Conference
Listen to webcast.
Jun 11, 2010
2010 Annual Meeting of Shareholders
NY
view map
Jun 10, 2010
9th Annual Needham Healthcare Conference
Listen to webcast.
View Presentation
955.6 KB
May 26, 2010
9:00 AM ET
Citi Investment Research 2010 Global Healthcare Conference
Listen to webcast.
View Presentation
783.8 KB
May 13, 2010
Bank of America Merrill Lynch 2010 Healthcare Conference
Listen to webcast.
View Presentation
5.2 MB
= add file to Briefcase
Print page
Email page
Stock Information
NASDAQ:REGN
$23.17
+ 0.69
Sep 2, 2010
11:30 AM ET
Quotes delay at least 20min., by eSignal.
3 Mo.
6 Mo.
1 Yr.
Shareholder Tools
Shareholder Briefcase
Printed Materials
Email Alerts
Download Library
REGN Snapshot
RSS News Feeds
Search Investor Relations
Investor site
Section only
Featured Report
2009
Annual Report and 10K
2010
Proxy Statement
2010 1st Quarter 10-Q
2008
Annual Report